Answers are grounded in this paper and cite their sources.
Demonstrates increased Na+ and glucose excretion in rats, indicating potential therapeutic effects.
Background 8‐Aminoguanosine and 8‐aminoguanine are K + ‐sparing natriuretics that increase glucose excretion. Most effects of 8‐aminoguanosine are due to its metabolism to 8‐aminoguanine. However, the mechanism by which 8‐aminoguanine affects renal function is unknown and is the focus of this investigation. Methods and Results Because 8‐aminoguanine has structural similarities with inhibitors of the epithelial sodium channel (ENaC), Na + /H + exchangers, and adenosine A 1 receptors, we examined the effects of 8‐aminoguanine on EN aC activity in mouse collecting duct cells, on intracellular pH of human proximal tubular epithelial cells, on responses to a selective A 1 ‐receptor agonist in vivo, and on renal excretory function in A 1 ‐receptor knockout rats. These experiments showed that 8‐aminoguanine did not block EN aC, Na + /H + exchangers, or A 1 receptors. Because Rac1 enhances activity of mineralocorticoid receptors and some guanosine analogues inhibit Rac1, we examined the effects of 8‐aminoguanine on Rac1 activity in mouse collecting duct cells. Rac1 activity was significantly inhibited by 8‐aminoguanine. Because in vitro 8‐aminoguanine is a purine nucleoside phosphorylase ( PNP ase) inhibitor, we examined the effects of a natriuretic dose of 8‐aminoguanine on urinary excretion of PNP ase substrates and products. 8‐Aminoguanine increased and decreased, respectively, urinary excretion of PNP ase substrates and products. Next we compared in rats the renal effects of intravenous doses of 9‐deazaguanine ( PNP ase inhibitor) versus 8‐aminoguanine. 8‐Aminoguanine and 9‐deazaguanine induced similar increases in urinary Na + and glucose excretion, yet only 8‐aminoguanine reduced K + excretion. Nsc23766 (Rac1 inhibitor) mimicked the effects of 8‐aminoguanine on K + excretion. Conclusions 8‐Aminoguanine increases Na + and glucose excretion by blocking PNP ase and decreases K + excretion by inhibiting Rac1.
No takes yet. Share an insight, caveat, or question.
Jackson et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: